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Circadian rhythms are established by transcription of clock genes and autoregulatory 
transcriptional feedback loops. In this issue, Xu et al. (2007) characterize mice expressing 
a human Per2 mutation identified in patients with familial advanced sleep phase syndrome. 
Their results reveal that PER2 phosphorylation, by CK1δ and other kinases, is surprisingly 
complex and has opposite effects on PER2 levels and period length.The ability to predict sunset, sunrise, 
and other time cues by circadian 
clocks exists in most organisms. In 
vertebrates, these clocks are based 
on cell-autonomous transcriptional 
feedback loops of clock proteins, 
such as the basic helix-loop-helix-
PAS domain transcription factors 
BMAL1, CLOCK, PER1, 2, 3, and 
CRY1, 2 (Lowrey and Takahashi, 
2004). These proteins establish a 
stable oscillation period of ?24 hr. 
CLOCK:BMAL1 heterodimers bind to 
DNA sequences (E boxes) and stim-
ulate transcription of output genes 
that regulate behavior, metabolism, 
and physiology. In addition, CLOCK:
BMAL1 activate Per and Cry tran-
scription. PER:CRY complexes form 
in the cytoplasm and translocate 
to the nucleus where they repress 
transcriptional activity of CLOCK:
BMAL1. A second feedback loop 
has also been identified, involving 
Rev-erbα transcription and repres-
sion of BMAL1 transcription. Built-in 
biochemical delays in the progres-
sion of these loops results in 24 hr 
rhythmicity.
Mutations in clock components or 
their regulators can affect rhythmic-
ity by altering the free-running period 
(τ, the period in which behavior con-
tinues to oscillate in the absence 
of external cues) and can result in 
circadian sleep disorders such as 
familial advanced sleep phase syn-
drome (FASPS) in humans (Toh et 
al., 2001; Xu et al., 2005). In con-22 Cell 128, January 12, 2007 ©2007 Elsetrast, with delayed sleep phase syn-
drome (extreme night owls), which 
commonly affects adolescents and 
improves with age, advanced sleep 
phase (extreme early birds) is a 
more specific phenotype (Jones et 
al., 1999). Toh et al. (2001) found a 
large FASPS pedigree with a serine 
to glycine substitution (S662G) in 
the hPER2 gene, with in vitro data 
suggesting a potential phosphoryla-
tion site by CK1ε). Another FASPS 
pedigree was later identified with 
a CK1δ threonine to alanine (T44A) 
mutation, an alteration shown to 
reduce activity of this enzyme in 
vivo (Xu et al., 2005). Interestingly, 
although introduction of the mutant 
T44A CK1δ transgene did shorten 
τ as expected in mice, it actually 
lengthens τ in Drosophila, suggest-
ing different regulatory mechanisms 
across species.
In this issue of Cell, Xu et al. 
(2007) characterize transgenic mice 
expressing hPER2 with the S662G 
mutation. When the hPER2 S662G 
transgene was introduced in wild-
type and mPer2 knockout animals, 
mice had a shorter τ, thus mimicking 
human FASPS. Furthermore, mice 
with a serine to aspartate (S662D) 
mutation in hPER2, which should 
mimic phosphorylation, had a longer 
τ. Together with prior studies of CK1δ 
T44A transgenic mice that have 
FASPS, this study validates mice 
models to functionally test human 
circadian mutations.vier Inc.Using the transgenic mice express-
ing phosphorylation site mutants of 
hPER2, the authors determined how 
PER2 phosphorylation at Ser662 may 
affect the working of the inner clock. 
Interestingly, Ser662 is the first in a 
series of five closely spaced serines, 
and phosphorylation of Ser662 facili-
tates phosphorylation of the other four 
residues by CK1. Previous studies had 
suggested the involvement of both 
CK1ε and CK1δ in the phosphorylation 
of PER2. Because of its role in FASPS, 
the authors therefore explored the 
role of CK1δ. The authors showed 
that modulating the levels of wild-type 
CK1δ did not affect τ in wild-type mice. 
Surprisingly, however, they found 
that decreased CK1δ gene dosage 
increased τ in both hPER2 S662G and 
S662D transgenic animals. Increased 
CK1δ gene dosage in short τ hPER2 
S662G transgenic mice made τ even 
shorter. These experiments indicate 
that CK1δ does not phosphorylate 
PER2 at Ser662 and probably influ-
ences the clock by phosphorylation 
of PER2 at other sites, or by phospho-
rylation of other circadian proteins. 
Additionally, because increasing CK1δ 
activity reduces τ, whereas phospho-
rylation at S662 prolonged τ, it is sug-
gested that phosphorylation at other 
PER2 sites leads to opposite effects 
on PER2 overall activity. This model is 
supported by in vitro and Drosophila 
studies suggesting that PER phospho-
rylation increases its degradation, an 
effect expected to reduce τ and thus 
figure 1. The Primary negative feedback Loop of the Circadian Clock
Clock/BMAL1 activate Per and Cry transcription. PER and CRY form a complex in the cytoplasm. 
Phosphorylation of PER by CK1ε/δ mediates PER degradation by the proteosome. Phosphoryla-
tion of PER2 on S662 (by an unidentified kinase) stabilizes PER2 potentially by causing its nuclear 
translocation or increased transcription. CRY and CK1 are also translocated into the nucleus. 
PER/CRY complexes inhibit the activity of CLOCK:BMAL1 as part of a negative feedback loop.opposite to what would be expected 
in the hPER2 S662G mutation where 
the site is lost.
The findings of Xu et al. (2007) 
are strongly supported by a recent 
in vitro study, which examined the 
equivalent serine 662 residue in the 
mouse PER2 protein (Ser659) and 
20 other phosphorylation sites on the 
PER protein (Vanselow et al., 2006). 
Here, increased stability and nuclear 
retention of PER2 was found when 
Ser659 was phosphorylated, whereas 
phosphorylation at other sites led to 
opposite effects, i.e., increased deg-
radation. Thus the general concept of 
a differential effect of various phos-
phorylation sites on PER activity may 
explain in vivo versus in vitro discrep-
ancies in the effects of various kinase 
mutations that regulate the clock 
(Gallego et al., 2006).
Taken together, these recent stud-
ies favor a model where clock timing 
is strongly regulated by expression, 
degradation, and/or nuclear entry and 
retention of PER2 and modulated by 
multiple states of PER2 phosphoryla-
tion, some of which are not depend-
ent on CK1ε/δ (Figure 1). The model 
is still sketchy, as differing effects 
of the PER2 FASPS mutation were 
reported on PER2 nuclear entry and 
degradation based on in vitro stud-ies. Vanselow et al. (2006) propose 
a model in which phosphorylation 
at the PER2 FASPS site is critical in 
mediating PER2 nuclear retention and 
repression of CLOCK:BMAL1 activ-
ity. PER2 degradation is primarily a 
consequence of increased cytoplas-
mic localization of PER2 protein that 
is phosphorylated at CK1-dependant 
sites distant from Ser662 and there-
fore undergoes proteasomal degra-
dation more quickly. Thus in FASPS, 
PER2:CRY complexes do not stay in 
the nucleus sufficiently long, thereby 
shortening τ. In the model proposed 
here by Xu et al. (2007), less PER2 is 
produced through an indirect effect of 
the FASPS mutation on PER2 expres-
sion. The normal rise and fall of PER2 
thus reaches critically lower levels 
earlier in the cycle, therefore short-
ening τ. The models thus agree upon 
the effects of distant phosphorylated 
residues (increased PER2 degrada-
tion) whereas they differ on the roles 
of S662 and proximal residues (higher 
PER2 levels through increased nuclear 
retention versus increased mRNA 
transcription). Why would reduced 
nuclear retention of PER2 and its 
shorter half-life in FASPS lead to a 
decrease in PER2 mRNA expression? 
There is evidence that CRY can stabi-
lize a CLOCK:BMAL1 complex that is Cell 128, inactive (leading to lower transcription 
in the face of elevated CLOCK:BMAL1 
levels) (Kondratov et al., 2006). Is the 
S662G PER2 mutation perhaps facili-
tating this action of CRY to decrease 
transcription of PER2? Another possi-
bility is that CLOCK:BMAL1 transcrip-
tion (of PER2) is likely coupled with 
proteosome degradation (Kwon et al., 
2006) as has been shown previously 
for nuclear receptors. If the S662G 
PER2 mutation interfered with the 
proteosome-mediated turnover of the 
CLOCK:BMAL1 activation complex, 
this could then lead to a decrease in 
PER2 transcription in FASPS.
The complex interactions observed 
here highlight the importance of 
understanding both transcriptional 
and posttranscriptional regulation of 
clock proteins. We expect that addi-
tional human circadian mutants will 
be revealed in the near future, helping 
us understand the inner working of 
the mammalian clock through careful 
studies in animal models.
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